Veeva Systems’ share price rose 11.6% on strong second-quarter results, raised earnings guidance and new orders for its AI CRM. Biogen and Regeneron’s decisions to deploy Vault CRM globally were also cited.
Veeva Systems’ latest second-quarter results provided a positive catalyst, and the company announced upward revisions to its earnings forecasts. In addition, the adoption of AI agents centered on Vault CRM was cited as a factor supporting new orders.
Among the company’s recent announcements, Biogen and Regeneron’s decisions to deploy Vault CRM globally were considered particularly significant in the results that exceeded expectations. These contracts suggest that AI-enabled CRM and tools are gaining the support of large customers.
Regarding the stock’s valuation, the company has provided revenue and profit forecasts through 2029, while an analyst report said its fair value estimate suggests downside from the current share price. At the same time, some believe that AI-related performance will determine the company’s future direction.